Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
Conditions
- Malignant Pleural Mesothelioma
Interventions
- BIOLOGICAL: rAd-IFN
- DRUG: Celecoxib Oral Product
- DRUG: Gemcitabine
Sponsor
Ferring Ventures Limited
Collaborators